NASDAQ:DERM Journey Medical (DERM) Stock Price, News & Analysis $3.29 -0.26 (-7.32%) Closing price 11/20/2026 03:58 PM EasternExtended Trading$3.34 +0.05 (+1.52%) As of 11/20/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Journey Medical Stock (NASDAQ:DERM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Journey Medical alerts:Sign Up Key Stats Today's Range$3.21▼$3.5750-Day Range$3.29▼$7.3852-Week Range$3.21▼$9.56Volume244,737 shsAverage Volume216,159 shsMarket Capitalization$92.88 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingHold Company Overview Journey Medical Corporation is a commercial-stage pharmaceutical company focused on developing and marketing prescription treatments for dermatological conditions. Founded in 2014 and based in Scottsdale, Arizona, the company primarily serves the U.S. market. Its portfolio includes treatments for conditions such as acne, rosacea, excessive underarm sweating and fungal skin infections. Products include Amzeeq and Zilxi, topical minocycline therapies; Qbrexza, a topical treatment for primary axillary hyperhidrosis; and the oral rosacea treatment Emrosi. Journey Medical markets its products through a U.S. commercial organization and works to expand its dermatology portfolio through product development, licensing and acquisitions.AI Generated. May Contain Errors. Read More Journey Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreDERM MarketRank™: 1.665731912505 of 5 starsJourney Medical scored higher than 33% of companies evaluated by MarketBeat, and ranked 694th out of 837 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingHold Consensus RatingJourney Medical has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 2 sell ratings.Upside PotentialJourney Medical has a consensus price target of $13.00, representing about 295.1% upside from its current price of $3.29.Amount of Analyst CoverageJourney Medical has only been the subject of 4 research reports in the past 90 days.Read more about Journey Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Journey Medical are expected to grow in the coming year, from ($0.19) to $0.18 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Journey Medical is -18.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Journey Medical is -18.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioJourney Medical has a P/B Ratio of 2.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.79% of the float of Journey Medical has been sold short.Short Interest Ratio / Days to CoverJourney Medical has a short interest ratio ("days to cover") of 15.07, which indicates bearish sentiment.Change versus previous monthShort interest in Journey Medical has recently increased by 3.25%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldJourney Medical does not currently pay a dividend.Dividend GrowthJourney Medical does not have a long track record of dividend growth. News and Social Media1.8 / 5News Sentiment-0.07 News SentimentJourney Medical has a news sentiment score of -0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 12 news articles for Journey Medical this week, compared to 2 articles on an average week.Search Interest1 people have searched for DERM on MarketBeat in the last 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Journey Medical insiders have not sold or bought any company stock.Percentage Held by Insiders14.53% of the stock of Journey Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions7.25% of the stock of Journey Medical is held by institutions.Read more about Journey Medical's insider trading history. Receive DERM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DERM Stock News HeadlinesHC Wainwright Estimates Journey Medical FY2026 EarningsNovember 19 at 1:42 AM | americanbankingnews.comJourney Medical CorpNovember 18, 2026 | markets.ft.comUnder 3 cents a nightBill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night. With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies. No re-bills and nothing to install. At $7, the only question is whether you get around to it.November 22 at 1:00 AM | Profits Run (Ad)FY2027 EPS Forecast for Journey Medical Reduced by AnalystNovember 16, 2026 | americanbankingnews.comJourney Medical (DERM) Q3 2026 Earnings Call TranscriptNovember 13, 2026 | finance.yahoo.comTranscript : Journey Medical Corporation, Q3 2026 Earnings Call, Nov 12, 2026November 12, 2026 | marketscreener.comMJourney Medical (DERM) Reports Q3 Earnings: What Key Metrics Have to SayNovember 12, 2026 | finance.yahoo.comJourney Medical Corporation (DERM) Q3 2026 Earnings Call TranscriptNovember 12, 2026 | seekingalpha.comSee More Headlines DERM Stock Analysis - Frequently Asked Questions How have DERM shares performed this year? Journey Medical's stock was trading at $7.71 at the start of the year. Since then, DERM stock has decreased by 57.3% and is now trading at $3.29. How were Journey Medical's earnings last quarter? Journey Medical Corporation (NASDAQ:DERM) released its quarterly earnings data on Thursday, November, 12th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.03. The business had revenue of $18.97 million for the quarter, compared to analysts' expectations of $20.32 million. Journey Medical had a negative trailing twelve-month return on equity of 16.07% and a negative net margin of 7.34%. Read the conference call transcript. When did Journey Medical IPO? Journey Medical (DERM) raised $39 million in an initial public offering on Friday, November 12th 2021. The company issued 3,520,000 shares at $10.00-$12.00 per share. Who are Journey Medical's major shareholders? Journey Medical's top institutional investors include First Eagle Investment Management LLC (1.71%), Marshall Wace LLP (0.69%), Goldman Sachs Group Inc. (0.30%) and State Street Corp (0.25%). Insiders that own company stock include Claude Maraoui, Ramsey Alloush, Justin Adam Smith and Joseph Benesch. View institutional ownership trends. How do I buy shares of Journey Medical? Shares of DERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/12/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (6d) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 6 days, DERM's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:DERM Previous SymbolNASDAQ:DERM CIK1867066 Webwww.jmcderm.com Phone480-434-6670FaxN/AEmployees58Year Founded2014Price Target and Rating Average Price Target for Journey Medical$13.00 High Price Target$13.00 Low Price Target$13.00 Potential Upside/Downside+295.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.18) Trailing P/E RatioN/A Forward P/E Ratio18.28 P/E GrowthN/ANet Income-$11.43 million Net Margins-7.34% Pretax Margin-7.32% Return on Equity-16.07% Return on Assets-5.26% Debt Debt-to-Equity Ratio0.56 Current Ratio1.48 Quick Ratio1.34 Sales & Book Value Annual Sales$61.86 million Price / Sales1.50 Cash FlowN/A Price / Cash FlowN/A Book Value$1.14 per share Price / Book2.89Miscellaneous Outstanding Shares28,230,000Free Float24,129,000Market Cap$92.88 million OptionableOptionable Beta1.14 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:DERM) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersPrediction: NVDA will “snap back” on this dateOthers paid $500 for the Snapback Indicator. For Black Friday, Base Camp Trading is offering lifetime access f...Base Camp Trading | SponsoredYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredGold Miners Post Record Cash Flows as AI Stocks WobbleGold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | SponsoredNoah’s Ark found?Scientists may have discovered Noah's Ark buried under a mountain in eastern Turkey, just two miles from the I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.